文献速递免疫规划

水痘疫苗接种建模:带状疱疹发病率未见大幅上升对外源性增强假说意味着什么

Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?
PubMed 文献 · Vaccine · 2021-12-18

研究采用水痘-带状疱疹病毒疾病的确定性仓室传播模型,模拟不同增强保护水平与持续时间,探索儿童普遍水痘疫苗接种对带状疱疹发病率的影响。结果显示,终身强保护使带状疱疹发病率稳定约60年后下降,终身中等保护及弱保护中等持续时间均导致下降,完全短保护导致小幅上升,完全中等保护导致最大上升。结论认为疫苗接种后带状疱疹发病率未出现大幅上升,在最初20-30年内可发生于强、中等或弱增强场景中。

要点

  • 终身强保护下带状疱疹发病率稳定约60年后下降。
  • 完全中等保护导致最大的带状疱疹发病率上升。
  • 疫苗接种后带状疱疹发病率未大幅上升可见于强、中等或弱增强场景。

核心结论

  • 水痘疫苗接种后带状疱疹发病率未出现大幅上升,尤其在最初20-30年内,可发生于强、中等或弱增强场景中。
  • 影响似乎取决于保护水平和保护持续时间的相互作用,二者决定基础再激活率和疫苗接种开始时易感人群比例。
  • 结论取决于观察整个群体还是特定年龄组。

研究设计与样本

  • 研究采用水痘-带状疱疹病毒疾病的确定性仓室传播模型,模拟不同增强保护水平和持续时间。

主要发现

  • 考虑总带状疱疹发病率,终身强保护使带状疱疹发病率稳定约60年后下降。
  • 终身中等保护导致带状疱疹发病率下降;弱保护中等持续时间也导致下降。
  • 完全短保护导致小幅带状疱疹发病率上升;完全中等保护导致最大的带状疱疹发病率上升。
  • 按年龄组的带状疱疹发病率显示,总发病率是各年龄组随时间相反升降趋势的结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For decades, assessments of the impact of universal varicella vaccination on the epidemiology of varicella and herpes zoster (HZ) have been made using mathematical modelling. Decreased virus circulation and the resulting diminished exogenous boosting have been predicted to lead to a surge in HZ incidence. Lately, the exogenous boosting hypothesis has been challenged due to a lack of an extensive surge in HZ incidence in countries with, by now long-standing universal varicella vaccination. METHODS: In a deterministic compartmental transmission model of varicella zoster virus disease, we model various levels and duration of protection from boosting to explore the impact of successful childhood varicella vaccination on HZ incidence. RESULTS: Considering total HZ incidence, lifelong and strong protection from boosting give a stable incidence of HZ for about 60 years followed by a decline, whereas lifelong intermediate protection leads to a decline. So does weak protection of intermediate duration. Full and short protection, lead to a small surge, while full and intermediate protection lead to the largest HZ surge. HZ incidence by age group show that total incidence is the result of opposing increasing and decreasing trends in the various age groups over time. CONCLUSIONS: The absence of an extensive surge in HZ incidence after varicella vaccination can, especially during the first 20-30 years, occur in either strong, intermediate or weak boosting scenarios. The impact seems to depend on an interplay of the protective level and duration of the protection in determining the basic reactivation rate and the proportion of the population that is susceptible at the start of vaccination. However, the picture depends on whether the entire population or specific age groups are observed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Widgren K, Tomba GS, Leung KY, et al. Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting? Vaccine. 2021. PMID: 34930603. doi:10.1016/j.vaccine.2021.11.063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。